Which Is the Ideal Treatment for Benign Diffuse and Multinodular Non-Toxic Goiters?

Front Endocrinol (Lausanne)

Thyroid Unit, Division of Endocrinology and Metabolism, University of São Paulo Medical School, Hospital das Clínicas, São Paulo , Brazil.

Published: May 2016


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Patients with large benign goiters often present local compressive symptoms that require surgical treatment, including dysphagia, neck tightness, and airway obstruction. In contrast, patients with such goiters who remain asymptomatic may be observed after exclusion of malignancy. The use of levothyroxine (LT4) to reduce the volume of the goiter is still a controversial treatment for large goiters, and the optimal surgical procedure for multinodular goiter is still debatable. Radioiodine is a safe and effective treatment option when used alone or in combination with recombinant human TSH. This review discusses current therapeutic options to treat diffuse and multinodular non-toxic benign goiters.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876491PMC
http://dx.doi.org/10.3389/fendo.2016.00048DOI Listing

Publication Analysis

Top Keywords

diffuse multinodular
8
multinodular non-toxic
8
benign goiters
8
ideal treatment
4
treatment benign
4
benign diffuse
4
non-toxic goiters?
4
goiters? patients
4
patients large
4
large benign
4

Similar Publications

DICER1 syndrome is a tumor-predisposition disorder caused by a germline pathogenic variant in DICER1. Pathogenic variants of DICER1 are the monogenic cause of various tumors including pleuropulmonary blastoma (PPB), ovarian sex cord-stromal tumors, and multinodular goiters. We present a family with a novel DICER1 pathogenic variant c.

View Article and Find Full Text PDF

Aim: To analyse the expression of early, intermediate and late neuronal immunomarkers in multinodular and vacuolating neuronal tumour (MVNT) and understand the histogenesis of this rare tumour.

Materials And Methods: This is a retrospective study over a period of 5 years and included seven cases. Demographic, radiological and histopathological features were assessed.

View Article and Find Full Text PDF

Rhabdomyosarcoma with EWSR1/FUS::TFCP2 fusion is an emerging subtype of rhabdomyosarcoma that rarely arises in skin. It is characterized by spindle and epithelioid morphology, and frequent expression of cytokeratin and anaplastic lymphoma kinase (ALK). We report a case of primary cutaneous rhabdomyosarcoma with FUS::TFCP2 fusion in a 59-year-old man who initially presented with an erythematous lesion on the chest that progressed to a mass-forming lesion 6 months before his hospital visit.

View Article and Find Full Text PDF

Background: Thyroid diseases are the second most common hormonal disorders, necessitating accurate diagnostics. Advances in artificial intelligence and radiomics have enhanced diagnostic precision by analyzing quantitative imaging features. However, reproducibility challenges arising from factors such as the field-of-view (FOV) zooming and segmentation variability limit the clinical application of radiomic-based models.

View Article and Find Full Text PDF

A 0.5-cm nodular thickening of the vagina was observed in a flying fox () that had been rescued after becoming entangled in fruit netting. Over the following 6 mo, the thickening progressed to diffuse multinodular mucosal thickening of both the vagina and anus.

View Article and Find Full Text PDF